| 1 | Healthcare costs in implantable cardioverter-defibrillator recipients: A real-life cohort study on 19,408 patients from the French national healthcare database | 2.2 | 5 | Citations (PDF) |
| 2 | Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study | 3.1 | 40 | Citations (PDF) |
| 3 | Therapeutic management and outcome of patients with advanced systemic mastocytosis treated with midostaurin: A comprehensive real‐life study in the French national healthcare database | 2.1 | 0 | Citations (PDF) |
| 4 | Innovative Approach for a Typology of Treatment Sequences in Early Stage HER2 Positive Breast Cancer Patients Treated With Trastuzumab in the French National Hospital Database | 1.9 | 3 | Citations (PDF) |
| 5 | Thyroid cancer incidence trends by histology in 25 countries: a population-based study | 21.7 | 557 | Citations (PDF) |
| 6 | Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database | 1.4 | 3 | Citations (PDF) |
| 7 | Adults at risk of pneumococcal disease in France | 1.5 | 10 | Citations (PDF) |
| 8 | Profiling global cancer incidence and mortality by socioeconomic development | 4.3 | 138 | Citations (PDF) |
| 9 | International trends in COPD mortality, 1995–2017 | 8.7 | 68 | Citations (PDF) |
| 10 | Thyroid cancer “epidemic” also occurs in low‐ and middle‐income countries | 4.3 | 107 | Citations (PDF) |
| 11 | International Patterns and Trends in Endometrial Cancer Incidence, 1978–2013 | 4.6 | 661 | Citations (PDF) |
| 12 | International trends in anal cancer incidence rates | 4.9 | 208 | Citations (PDF) |
| 13 | Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013 | 9.9 | 193 | Citations (PDF) |
| 14 | RE: Anal cancer: different epidemiological and clinical definitions | 4.9 | 34 | Citations (PDF) |
| 15 | Breast Cancer Screening for Women at Average Risk | 0.5 | 2 | Citations (PDF) |
| 16 | U.S. Burden of Cancer by Race and Ethnicity According to Disability-Adjusted Life Years | 3.2 | 32 | Citations (PDF) |
| 17 | Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening | 251.5 | 211 | Citations (PDF) |
| 18 | State-Level Cancer Mortality Attributable to Cigarette Smoking in the United States | 10.6 | 120 | Citations (PDF) |
| 19 | Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group | 4.3 | 276 | Citations (PDF) |
| 20 | Reprint of: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 | 4.9 | 58 | Citations (PDF) |
| 21 | Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.1 | 5,638 | Citations (PDF) |
| 22 | International Variations and Trends in Renal Cell Carcinoma Incidence and Mortality | 2.1 | 863 | Citations (PDF) |
| 23 | Global cancer statistics, 2012 | 251.5 | 25,078 | Citations (PDF) |
| 24 | Potentially preventable premature lung cancer deaths in the USA if overall population rates were reduced to those of educated whites in lower-risk states | 1.7 | 25 | Citations (PDF) |
| 25 | Tumor size and stage of breast cancer in Côte d'Ivoire and Republic of Congo – Results from population-based cancer registries | 2.3 | 14 | Citations (PDF) |
| 26 | Breast Cancer Screening for Women at Average Risk | 16.5 | 1,517 | Citations (PDF) |
| 27 | Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition | 62.1 | 1,751 | Citations (PDF) |
| 28 | Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 | 62.1 | 2,474 | Citations (PDF) |
| 29 | International Variation in Female Breast Cancer Incidence and Mortality Rates | 1.1 | 692 | Citations (PDF) |
| 30 | Convergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988–2010 | 4.9 | 153 | Citations (PDF) |
| 31 | Testicular cancer incidence to rise by 25% by 2025 in Europe? Model-based predictions in 40 countries using population-based registry data | 4.9 | 154 | Citations (PDF) |
| 32 | International Variations and Trends in Testicular Cancer Incidence and Mortality | 2.1 | 241 | Citations (PDF) |
| 33 | International Variations in Bladder Cancer Incidence and Mortality | 2.1 | 313 | Citations (PDF) |
| 34 | International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women | 2.6 | 352 | Citations (PDF) |
| 35 | International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? | 4.3 | 575 | Citations (PDF) |
| 36 | Worldwide trends in cervical cancer incidence: Impact of screening against changes in disease risk factors | 4.9 | 449 | Citations (PDF) |
| 37 | Patterns and Trends in Human Papillomavirus-Related Diseases in Central and Eastern Europe and Central Asia | 3.1 | 94 | Citations (PDF) |
| 38 | Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 | 4.9 | 4,668 | Citations (PDF) |
| 39 | Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions | 62.1 | 549 | Citations (PDF) |
| 40 | Global Burden of Human Papillomavirus and Related Diseases | 3.1 | 1,449 | Citations (PDF) |
| 41 | Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer | 2.5 | 81 | Citations (PDF) |
| 42 | International Variation in Prostate Cancer Incidence and Mortality Rates | 2.1 | 1,358 | Citations (PDF) |
| 43 | Prostate cancer incidence and mortality trends in 37 European countries: An overview | 4.9 | 269 | Citations (PDF) |
| 44 | Effect of lookback period length on disease incidence estimates in claims databases | 0.0 | 0 | Citations (PDF) |